Nuhey News

We talk about the MARKET

The Global Biopharmaceutical Fermentation Systems Market to show 4.9% CAGR from 2022-28

Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation.

The global Biopharmaceutical Fermentation Systems market size is projected to reach US$ 13130 million by 2028, from US$ 9380.9 million in 2021, at a CAGR of 4.9% during 2022-2028.

In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Fermentation Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Fermentation Systems market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Fermentation Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Fermentation Systems market.

Request for a free sample or purchase this report at:

Biopharmaceutical Fermentation Systems market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Fermentation Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Fermenters
  • Bioprocess Analyzers
  • Process Monitoring Devices
  • Culture & Media Preparation
  • Culture Media, Buffers & Inducers
  • Others

Segment by Application

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Contract Research Organizations
  • Academic Research Institutes
  • Others

By Company

  • GE Healthcare
  • Thermo Fisher Scientific
  • Danaher
  • Sartorius StedimBiotech
  • Merck
  • Eppendorf
  • Roche
  • Nova Biomedicals
  • Lonza
  • Becton
  • Dickinson and Company
  • GEA

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479